Suchergebnisse - "Devlin, Sean M"

PubPharm (186)

1

Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma

enthalten in: Journal of hematology & oncology | 2024

von Leithner, D. | Flynn, J. | Devlin, S. | +25

2

Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma

enthalten in: Journal of hematology & oncology | 2024

von Leithner, D. | Flynn, J. | Devlin, S. | +25

3

Racial/ ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation

enthalten in: Blood advances | 2024

von Fingrut, W. | Davis, E. | Archer, A. | +13

4

High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer

enthalten in: Blood advances | 2024

von Stonestrom, A. | Menghrajani, K. | Devlin, S. | +15

5

Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation

enthalten in: Bone marrow transplantation | 2024

von Melica, G. | Preston, E. | Palazzo, M. | +9

6

Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia

enthalten in: American journal of hematology | 2023

von Nath, K. | Lee, J. | Elko, T. | +19

7

The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation

enthalten in: British journal of haematology | 2023

von Elias, S. | Brown, S. | Devlin, S. | +20

8

Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma

enthalten in: Leukemia & lymphoma | 2023

von Dahi, P. | Kenny, S. | Flynn, J. | +12

9

Author Correction : Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

enthalten in: Nature medicine | 2023

von Smith, M. | Dai, A. | Ghilardi, G. | +46

ErratumFor: Nat Med. 2022 Apr;28(4):713-723. - PMID 35288695

10

Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma

enthalten in: Blood advances | 2023

von Scordo, M. | Flynn, J. | Gonen, M. | +19

CommentIn: Blood Adv. 2024 Feb 13;8(3):797-798. - PMID 38191740

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]